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Hemangiomas are the most common benign tumors found in the liver, typically asymptomatic, solitary, and incidentally
discovered. Although vascular in nature, they rarely bleed. We report a case of a 52-year-old woman with a previously stable
hemangioma who presented to our hospital with signs and symptoms indicative of spontaneous rupture. We review the literature,
focusing on diagnosis and management of liver hemangiomas.
1.Case
A 52-year-old Hispanic woman with history of a stable liver
mass of undetermined etiology diagnosed over ten years
ago presented to our institution with increasing right upper
quadrant abdominal pain for one month that had intensiﬁed
within the last two weeks. Pain intensity was rated 10 out
of 10 and increased with deep inspiration. She denied any
other associated symptoms, relieving or exacerbating factors.
She denied any history of icteric illnesses in the past, any
excessive alcohol use, or any parenteral risk factors for viral
hepatitis. She had been on an oral contraceptive brieﬂy in
her mid-thirties. Her past medical history was negative for
parenchymal liver disease but noted for hypertension, type
2 diabetes mellitus, dyslipidemia, obesity, and two previous
uncomplicated pregnancies carried to term. Her surgical his-
tory was noted for a hysterectomy for dysfunctional uterine
bleeding. Her social and family history was unremarkable.
On exam, her vital signs were stable and her body mass
index was 31. She was anicteric with a regular heart rate. Her
lungs were clear, and abdominal exam was noted for right
upper quadrant tenderness, nondistended abdomen without
a palpable spleen. She had good peripheral pulses and
capillary reﬁll, without evidence of edema. Her laboratory
investigation revealed an unremarkable complete blood cell
count, complete metabolic panel, coagulation studies, and
viral hepatitis serologies. A computed tomography of her
abdomen revealed a 6.2 × 5.9 × 4.1-centimeter exophytic
lesion arising from the posteroinferior aspect of the right
liver lobe with a small amount of ﬂuid tracking inferior
to the lesion into the right parapelvic gutter suggestive of
hemorrhage (Figures 1, 2, 3,a n d4). No additional hepatic
lesions were identiﬁed. There was no radiographic evidence
of cirrhosis. She was admitted and underwent laparoscopic
resection of the liver lesion. Frank hemoperitoneum was
absent at laparotomy. The resected specimen consisted of a
108-gram, 10 × 6 × 3cm section of liver that contains a 7.5
× 4 × 3.5cm gray tan, ﬁrm, well-circumscribed, nonencap-
sulated mass with dilated spaces ranging from 0.1 to 0.5cm.
The adjacent liver parenchyma was grossly unremarkable.
On histologic examination, the mass showed a proliferation
of cavernous vascular spaces with thickened myxoid walls
and ﬂattened endothelial lining without cytologic atypia or
mitotic activity. The tumor showed extensive areas of dense2 International Journal of Hepatology
Figure 1: Unenhanced computed tomography of the liver demon-
strates a 53.5mm heterogeneous area in segment six (arrow).
Figure 2: Contrast-enhanced computed tomography of the
abdomen in the coronal plane demonstrates intralesional areas of
arterial enhancement (arrow). There is a small amount of paracolic
gutter ﬂuid.
and loose ﬁbrous tissue made of collagen and elastic ﬁbers,
degenerative changes, and hyalinization ﬁndings diagnostic
of sclerosing (ancient) hemangioma (Figure 5).
2. Discussion
2.1. Background. Hemangiomas are the most common
benign tumors of the liver, found in one series up to
7% of autopsies [1]. Most hemangiomas are cavernous, in
contrast to the peripheral hemangiomas of the capillary
type [2, 3]. It is well established that hemangiomas have
a female predilection in a ratio of 5:1. They are primar-
ily discovered incidentally during abdominal imaging and
Figure 3: Reimaging of the abdomen with computed tomography
three days subsequent to the original study demonstrates further
increase in size of the ruptured hemangioma, and it now measures
61.5mm.
Figure 4: Reimaging of the abdomen with computed tomography
three days subsequent to the original study in the coronal plane
exhibits an increase in the amount of paracolic gutter ﬂuid
(arrowheads), and the craniocaudal dimension of the hemangioma
is now 73.8mm.
mainly present in individuals forty to ﬁfty years old [4].
Hemangiomas usually present as solitary lesions, but in
approximately 10% of the cases more than one lesion is
identiﬁed [5, 6]. The pathogenesis of hemangiomas has not
been elucidated, but there are two competing theories. The
ﬁrst theory supports the notion that there is overexpression
of angiogenic factors such as vascular endothelial growth
factor, basic ﬁbroblast growth factor, and metalloproteinases
as well as downregulation of some inhibitors of angiogenesis,
such as tissue inhibitor of metalloproteinase-I. The secondInternational Journal of Hepatology 3
(a)
(b)
(c)
(d)
Figure 5: (a) Liver parenchyma with adjacent nonencapsulated
mass(H&E,20x),(b)tumorwithaproliferationofthickened blood
vessels with myxoid changes (H&E, 400x), (c) the hemangioma
shows areas of hyalinized ﬁbrosis (H&E, 400x), and (d) areas of
loose connective tissue within the tumor (H&E, 400x).
theory is that the presence of liver hemangiomas involves
a genetic background of mutations [7–9]. Zhang et al.
presumed that metalloproteinases accumulate in the endo-
plasmic reticulum of the tumor cells, causing self-digestion
and vacuole formation [10]. Additionally, Hu et al. showed
the cavernous hemangioma cell to downregulate Derlin-
1, a protein that when overexpressed induces the dilated
endoplasmic reticulum to return to its normal size [11].
Clearly further studies are needed on the pathogenesis of
liver hemangiomas and their association with pregnancy,
oral contraceptives, and androgen use.
2.2. Diagnosis of Liver Hemangioma, Imaging Modalities, and
Role of Biopsy. The imaging modality that is primarily used
for the diagnosis of liver hemangiomas is the ultrasound.
Characteristically, on ultrasound, the hemangioma is a
hyperechoic lesion, predominantly found in the posterior
segment of the right liver lobe located inferior to Glis-
son’s capsule, without a peripheral hypoechoic halo and/or
hypoechoic center [12, 13]. It is noteworthy that, in patients
with fatty liver, hemangiomas can appear hypoechoic and in
those with severe fatty inﬁltration can be hyperattenuated,
mimicking hypervascular tumors. Ultrasound with contrast
c a nb eu s e da sa na l t e r n a t i v et oc o m p u t e dt o m o g r a p h y( C T )
or magnetic resonance imaging (MRI) for undetermined
lesions [1]. On triphasic CT, hemangiomas are typically
described as having peripheral puddles, ﬁlling centripetally,
and enhancing in delayed images. MRI is the best, albeit
most expensive imaging modality, demonstrating peripheral
enhancement,centripetalprogression,andhyperintensityon
T2 with hypointensity on T1 imaging [14]. Overall, it has
been reported that 10% of hemangiomas cannot be reliably
diagnosed with imaging methods alone [1, 15].
Grossly hemangiomas are described as “spongy” with
vascular compartments of various sizes separated by ﬁbrous
tissue. Thrombi may be present and are well separated from
the normal liver parenchyma despite the absence of a ﬁbrous
capsule. They express CD31, CD3 markers, and factor VIII-
related antigen among other markers [12]. Hemangioma-
like vessels are found extending 1-2cm around giant (>4cm
in diameter) hemangiomas. Phleboliths and thrombi as well
as sclerosis can be found in liver hemangiomas. Sclerosed
hemangiomas form, from the center out, have collagenous
elastic ﬁbers and are devoid of vascular compartments. The
diagnosis of a sclerosed hemangioma is often diﬃcult to
make, but is suggested by the presence of small peripheral
vessels in the pathology specimen [12]. Given the vascular
nature of liver hemangiomas, liver biopsy was in the past
considered unsafe and not recommended; however, now
it is considered relatively safe to perform, especially when
imaging is nondiagnostic [13]. Caution is advised for biopsy
of such lesions in question when hepatocellular carcinoma
remains in the diﬀerential diagnosis and should then only
be considered when other methods of diagnosis have been
thoroughly exhausted given concerns about seeding the
biopsy tract.
2.3. Management of Large and Ruptured Liver Hemangiomas.
Liver hemangiomas usually do not cause symptoms unless4 International Journal of Hepatology
their diameter exceeds 4cm. If smaller, they very rarely
cause symptoms and almost universally the liver enzymes
are within normal limits (unless there is parenchymal liver
disease) [12]. The majority of symptomatic patients present
with abdominal pain, abdominal fullness, indigestion, and
abdominal distention. Anemia, thrombocytopenia, and rare
syndromes such as the Kasabach-Merritt syndrome (a con-
sumptive coagulopathy) or Bornman-Terblanche-Blumgart
syndrome (fever and abdominal pain) have been reported
[3, 14, 16] .R u p t u r eo fl i v e rh e m a n g i o m a si sv e r yr a r e[ 17,
18]. The ﬁrst case was reported by Sewell [3]a n dH a e f e n
[19]. There are few cases of hemangioma rupture reported
in the literature; the vast majority of giant hemangiomas
are larger than 4cm in diameter, some of which presented
with rupture during pregnancy, when hemangiomas charac-
teristically increase in size. In our patient, the hemangioma
apparently ruptured but without causing hemodynamic
instability. Perhaps, as this hemangioma was sclerosed on
histological examination, it may have contributed to the
subacute presentation of our patient.
There are a number of interventions used to treat
symptomatic hemangiomas. The ﬁrst report of surgery for
a hemangioma was by Karp in 1931. In a study from Mayo
clinic including 49 cases of hemangiomas exceeding 4cm
in diameter, 13 patients underwent surgery, from simple
excision to hepatic lobectomy and 36 other patients were
observed for 15 years [20]. Rupture was not observed in
the latter group. Despite this, Corigliano et al. suggested
that hemangiomas with a diameter greater than 10cm have
a higher risk for internal bleeding, growth, and rupture,
and therefore preventive excision is recommended even if
asymptomatic [18]. The Pringle maneuver, enucleation with
temporarily inﬂow occlusion, is considered to be the treat-
ment of choice for large hemangiomas due to less blood loss
and postoperative complications [21]. Complications may
includeinfection,sepsis,ﬂuidcollectionaroundtheliver,and
paralytic ileus secondary to abdominal ﬂuid collection [22].
Embolization is another means of treating a symptomatic or
very large lesion, and it should be targeted at the hepatic
artery branches that feed the lesion [23–25]. The most
common complications of embolization are abdominal pain,
fever, and nausea, with very rare complications including
sepsis and migration of the thrombotic material. It has been
recommended that embolization can be performed prior to
resection of giant hemangiomas in order to diminish future
complications and reduce intraoperative blood loss. Other
less common treatment modalities include radiation therapy
and liver transplantation [22, 26, 27].
We reported a case of a ruptured giant hepatic heman-
gioma in a nonpregnant woman that was managed with
hepatic resection. In the literature, there are few reported
cases of spontaneously ruptured liver hemangiomas, mostly
c a v e r n o u st y p e ,m o s to fw h i c hw e r et r e a t e du r g e n t l yw i t h
resection or transarterial embolization due to extensive
hemoperitoneum and hemodynamic instability. In our case,
the patient presented and remained in a stable condition
throughout the hospitalization until her surgery. Despite
having imaging ﬁndings of giant hemangioma rupture, she
never became hemodynamically unstable. We could not
identify cases related to spontaneous rupture of a sclerosing,
(ancient)liverhemangioma.APubMedsearchoftheEnglish
literature with the keywords “spontaneous rupture, hepatic-
liver and sclerosed or sclerosing hemangioma,” yielded no
results. Of course, the lack of references on spontaneous
sclerosing liver hemangioma rupture may be partially due to
insuﬃcient or no reporting of pathology ﬁndings in some of
the published cases. Our case suggests that spontaneous rup-
ture may occur in a cavernous liver hemangioma with abun-
dant sclerosing features; however, this may be responsible
forasubacutepresentation, not signiﬁcant hemoperitoneum
and no hemodynamic instability, as happened with our
patient. In conclusion, a hemangioma is the most common
benign lesion found in the liver. Although typically an
incidentalﬁnding,discussedpotentiallyseverecomplications
can occur requiring prompt intervention.
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